SpicyIP Weekly Review (January 22- January 28)
SpicyIP
JANUARY 29, 2024
In a major development concerning the Ibrutinib patent, DHC restrains generic manufacturers from manufacturing and marketing the life-saving anti-cancer drug. Tech giants Nokia and Oppo enter into a cross-licensing agreement ending their patent disputes across multiple jurisdictions! But what about the public interest?
Let's personalize your content